Finance

Lists
MARKSANS:NSE
Marksans Pharma Ltd
₹309,15
+0,42%
(+1,30) 1D
16 Okt., 10:54:36 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MARKSANS...
Open
₹308,10
High
₹311,20
Low
₹306,00
Mkt. cap
140,01 mjd
Avg. vol.
2,25 m
Volume
293,41 k
Dividend
0,29%
Quarterly dividend
₹0,23
Ex-dividend date
20 Aug. 2026
P/E ratio
27,10
52-wk high
₹350,95
52-wk low
₹155,00
EPS
₹11,41
Shares outstanding
409,31 m
No. of employees
2 k
Open
₹308,10
High
₹311,20
Low
₹306,00
Mkt. cap
140,01 mjd
Avg. vol.
2,25 m
Volume
293,41 k
Dividend
0,29%
Quarterly dividend
₹0,23
Ex-dividend date
20 Aug. 2026
P/E ratio
27,10
52-wk high
₹350,95
52-wk low
₹155,00
EPS
₹11,41
Shares outstanding
409,31 m
No. of employees
2 k
News stories
From web sources and news partners
About Marksans Pharma Ltd
CEOMark B. Saldanha
Employees1,68 k
Founded1992
Headquarters-
SectorPharmaceutical industry
Last report
13 Aug. 2026
Fiscal period
Q1 2027
₹3,47 / ₹3,30
+5,15%beat
Revenue / Est. (INR)
8,41 mjd / 8,50 mjd
-1,11%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
7,20 mjd
7,54 mjd
8,56 mjd
8,41 mjd
Cost of goods sold
3,09 mjd
3,16 mjd
4,51 mjd
3,43 mjd
Cost of revenue
3,09 mjd
3,16 mjd
4,51 mjd
3,43 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,04 mjd
1,12 mjd
1,21 mjd
1,14 mjd
Operating expense
2,94 mjd
3,02 mjd
2,33 mjd
3,09 mjd
Total operating expenses
6,03 mjd
6,18 mjd
6,85 mjd
6,53 mjd
Operating income
1,18 mjd
1,36 mjd
1,72 mjd
1,88 mjd
Other non operating income
215,72 m
201,44 m
-441,86 m
63,99 m
EBT including unusual items
1,33 mjd
1,51 mjd
2,00 mjd
2,07 mjd
EBT excluding unusual items
1,33 mjd
1,51 mjd
1,99 mjd
2,07 mjd
Income tax expense
341,95 m
369,34 m
509,66 m
471,64 m
Effective tax rate
25,65%
24,52%
25,48%
22,83%
Other operating expenses
1,64 mjd
1,65 mjd
881,88 m
1,70 mjd
Net income
982,50 m
1,13 mjd
1,48 mjd
1,57 mjd
Net profit margin
13,64%
15,01%
17,30%
18,69%
Earnings per share
-
2,50
3,27
3,47
Interest and investment income
-
-
276,78 m
-
Interest expense
-58,15 m
-59,35 m
-63,11 m
-
Net interest expenses
-58,15 m
-59,35 m
213,67 m
-
Depreciation and amortization charges
269,16 m
243,27 m
242,88 m
248,64 m
EBITDA
1,43 mjd
1,50 mjd
1,87 mjd
2,04 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme